BackgroundDespite possible benefits for growth, milk is costly to include in foods for undernourished children. Furthermore, the relative effects of different milk components, milk protein (MP), and whey permeate (WP) are unclear. We aimed to assess the effects of MP and WP in lipid-based nutrient supplement (LNS), and of LNS itself, on linear growth and body composition among stunted children.Methods and findingsWe performed a randomized, double-blind, 2 × 2 factorial trial among 12 to 59 months old stunted children in Uganda. Children were randomized to 4 formulations of LNS with MP or soy protein isolate and WP or maltodextrin (100 g/day for 12 weeks) or no supplementation. Investigators and outcome assessors were blinded; however, participants were only blinded to the ingredients in LNS. Data were analyzed based on intention-to-treat (ITT) using linear mixed-effects models adjusted for age, sex, season, and site. Primary outcomes were change in height and knee-heel length, and secondary outcomes included body composition by bioimpedance analysis (ISRCTN13093195).Between February and September 2020, we enrolled 750 children with a median age of 30 (interquartile range 23 to 41) months, with mean (± standard deviation) height-for-age z-score (HAZ) −3.02 ± 0.74 and 12.7% (95) were breastfed. The 750 children were randomized to LNS (n= 600) with or without MP (n= 299 versusn= 301) and WP (n= 301 versusn= 299), or no supplementation (n= 150); 736 (98.1%), evenly distributed between groups, completed 12-week follow-up. Eleven serious adverse events occurred in 10 (1.3%) children, mainly hospitalization with malaria and anemia, all deemed unrelated to the intervention.Unsupplemented children had 0.06 (95% confidence interval, CI [0.02, 0.10];p= 0.015) decline in HAZ, accompanied by 0.29 (95% CI [0.20, 0.39];p< 0.001) kg/m2increase in fat mass index (FMI), but 0.06 (95% CI [−0.002; 0.12];p= 0.057) kg/m2decline in fat-free mass index (FFMI).There were no interactions between MP and WP. The main effects of MP were 0.03 (95% CI [−0.10, 0.16];p= 0.662) cm in height and 0.2 (95% CI [−0.3, 0.7];p= 0.389) mm in knee-heel length. The main effects of WP were −0.08 (95% CI [−0.21, 0.05];p= 220) cm and −0.2 (95% CI [−0.7; 0.3];p= 403) mm, respectively. Interactions were found between WP and breastfeeding with respect to linear growth (p< 0.02), due to positive effects among breastfed and negative effects among non-breastfed children.Overall, LNS resulted in 0.56 (95% CI [0.42, 0.70];p< 0.001) cm height increase, corresponding to 0.17 (95% CI [0.13, 0.21];p< 0.001) HAZ increase, and 0.21 (95% CI [0.14, 0.28];p< 0.001) kg weight increase, of which 76.5% (95% CI [61.9; 91.1]) was fat-free mass. Using height-adjusted indicators, LNS increased FFMI (0.07 kg/m2, 95% CI [0.0001; 0.13];p= 0.049), but not FMI (0.01 kg/m2, 95% CI [−0.10, 0.12];p= 0.800). Main limitations were lack of blinding of caregivers and short study duration.ConclusionsAdding dairy to LNS has no additional effects on linear growth or body composition in stunted children aged 12 to 59 months. However, supplementation with LNS, irrespective of milk, supports linear catch-up growth and accretion of fat-free mass, but not fat mass. If left untreated, children already on a stunting trajectory gain fat at the expense of fat-free mass, thus nutrition programs to treat such children should be considered.Trial registrationISRCTN13093195